Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Ivacaftor withdrawal syndrome: A rare but potentially life-threatening consequence from a life-saving medication

Ivacaftor withdrawal syndrome: A rare but potentially life-threatening consequence from a life-saving medication

Resource Type

CF Research News

Authors

James M Clegg, Kelsey W Malloy, Rebekah F Brown, Alison G Grisso, Andrew G Sokolow

References

J Cyst Fibros. 2021 Aug 11;S1569-1993(21)01340-0. doi: 10.1016/j.jcf.2021.07.021.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Pulmonology [4]

Keywords

Highly effective modulator therapy [5]
Ivacaftor withdrawal syndrome [6]

Date

Wednesday, August 11, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/ivacaftor-withdrawal-syndrome-rare-potentially-life-threatening

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00217R1_FINAL_Clegg_141121.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34391678/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/pulmonology [5] https://www.ecfs.eu/research-article-keywords/highly-effective-modulator-therapy [6] https://www.ecfs.eu/research-article-keywords/ivacaftor-withdrawal-syndrome [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines